Hormonal therapy in metastatic prostate cancer: current perspectives and controversies
Ever since the introduction of androgen deprivation therapy (ADT) in prostate cancer, various controversial aspects of hormonal therapy have come to light. There has been tremendous progress in this area, marked by several important developments in the availability of various new androgen-suppressin...
Main Authors: | Manish Garg, Vishwajeet Singh, Manoj Kumar, Satya Narayan Sankhwar |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2013-09-01
|
Series: | Oncology Reviews |
Subjects: | |
Online Access: | http://www.oncologyreviews.org/index.php/or/article/view/226 |
Similar Items
-
Eighty Years of Targeting Androgen Receptor Activity in Prostate Cancer: The Fight Goes on
by: Eva Estébanez-Perpiñá, et al.
Published: (2021-01-01) -
Strategies to Re-Sensitize Castration-Resistant Prostate Cancer to Antiandrogen Therapy
by: Belén Congregado Ruiz, et al.
Published: (2023-04-01) -
Metastatic Hormone-Sensitive Prostate Cancer (mHSPC): Advances and Treatment Strategies in the First-Line Setting
by: Kenrick Ng, et al.
Published: (2020-06-01) -
Current status of endocrine therapy in localized prostate cancer: cure has become a strong possibility
by: Fernand Labrie
Published: (2004-02-01) -
Mechanisms of Androgen Receptor Agonist- and Antagonist-Mediated Cellular Senescence in Prostate Cancer
by: Miriam Kokal, et al.
Published: (2020-07-01)